There are 2 steps to submitting your applications:
|
1 |
E-Submit the PharmCAS ApplicationOnce your PharmCAS Application and Supplemental Application are both complete, log in to PharmCAS and electronically submit your PharmCAS Application. |
|---|---|
|
2 |
Submit the Supplemental Application to UCSF
|
Deadline: You must e-submit your PharmCAS application on or before midnight Eastern Standard Time on November 1, 2010. You must mail all components of your Supplemental Application so that they are postmarked on or before November 1, 2010. Late applications will not be considered under any circumstances.
To obtain evidence of when you mailed your application or receive confirmation that its delivery was successful, use services provided by your delivery agent, such as those provided by the United States Postal Service. These options are not required; we describe them here for your convenience.
Note: Due to the high volume of applications and supporting material we receive, we are unable to respond to any inquiries requesting confirmation of receipt of materials.
|
If you want... |
Select... |
You... |
|---|---|---|
|
Evidence of when you mailed your supplemental application |
Leave the post office with a receipt indicating the date of mailing and the address to which you mailed it. |
|
|
Confirmation that your supplemental application was delivered successfully |
Can confirm the date and time of delivery via telephone or Web. |
|
|
Both of the above |
USPS Certified Mail |
Get both of the above. |
You can expect to wait at least 1 month before hearing any notification from our office regarding receipt of your application materials. During this time, PharmCAS and our office process and verify applications.
See After submitting the applications.
To reach this page quickly or share it with others, use pharmacy.ucsf.edu/go/supp/submit, which redirects to a longer URL.
Go To: Supplemental Application
Although not required reading, you'll find additional comments in Save the Drama...., a blog post by Admissions Director Joel W. Gonzales.